An expert alert of the purchase of Chinese insulin needles

Máximo González Jurado alert to buy Chinese insulin needles

Only five regions avoid them

Link ... hinas-6914

The president of the General Nursing Council, Máximo González Jurado, has denounced the purchase of insulin needles “cheaper and Chinese that cause damage and ulcers in the patient.This is happening in almost all of Spain and it is not the solution.If there is no money you have to say it clearly. ”According to González Jurado, “there is a community directive that establishes the biosafety and marks that the needles must be retractile so that there are no risks of any kind, as well as the quality.However, the public purchase contests of material today are not being made in principle of security or quality, but for price.They are competing as biosecurity devices that are not because they are cheaper.If the technical characteristics are not detailed scientifically, they may not be safe and the costs are much lower.This is detrimental to the patient and the federation of diabetic patients has been claiming it for a long time.We are not against cost reduction, but whenever we are within the security line. ”

Regarding this community directive that came out two years ago, he added that “Spain is not complying with it although it still has until May next year to capture it in the legal system.So far only five autonomous communities have created legal regulations to guarantee that right.They are Madrid - which was the first in 2005-, Balearic Islands, Galicia, Navarra and Castilla La Mancha ”.

Máximo González Jurado has made these statements in the presentation of a multidisciplinary report on therapeutic adhesion in chronic diseases.“20 percent of patients are chronic and consume 80 percent of the health budget.In addition, according to the demographic data we have, in 2050 50 percent of the population will be over 60 years.And one of the biggest problems we have in the chronicles is the lack of adhesion to treatment.It is estimated that breach affects almost 50% of patients with chronic treatments and 20% of acute. ”This reduces the patient's quality of life, puts his health at risk and generates important costs derived from emergency visits, tests and drugs necessary to counteract the aggravation of the disease.As highlighted by the president of the General Nursing Council, "a third of hospital income is due to therapeutic breach and despite everything, health plans and health policies rarely take this problem into consideration."

González Jurado gives several non -compliance data.

Begoña Barragán has the patient's point of view.
The most common causes of poor therapeutic adhesion are oblivion, ignorance, demotivation and fear of adverse effects.The factors that influence the most are the age, sociocultural level and the lack of training of the health professional when teaching the patient how to take their medication and foster self -care.Hence, one of the most effective strategies to avoid breach consists in educating the patient about their illness, individually and group, reinforcing motivation and awareness.The use of telephone calls or sending letters that help the patient remember appointments with the health professional or that foster compliance can also help increase adhesion.

In a more practical field, the report presented proposes the use of control and self -medication cards,the realization of personalized dosing programs, the learning of techniques and the use of material that allows the self -control of the disease (tensiometer in hypertensive, for example) and foster rewards in case of compliance greater than 90 percent (congratulations, increase in thetime between appointments ...).

Ignorance of patients

According to Begoña Barragán, vowel of the Spanish forum of Patients and President of Gepac, the main problem of patients is the ignorance of the disease and treatment."The patient needs to be well formed by the health professionals who attend to him and here the patient associations also have a very important role."And he added that “with the current economic crisis the situation is more bleeding.For example, diabetic sugar control strips are being reduced, and if the patient is measured, the risk of this person then needs a kidney transplant.We are not saving money.We are putting the lives of many patients at risk. ”

I don't know what needles he talks ... I insuffer?Braun?
In addition to those only I know the BD and those of Novonordisk

Well, it doesn't surprise me, because in my center the BD no longer serves, now they are shit of a use with the fat cap and get fatal!

U.U

What brand are they?